RECENT FUNDING ROUNDS
|47 Labs||Healthcare through neuro-simulation.||Pre Seed|
|DOSE||In-game currency of the OliveX, fitness metaverse.||Private Round||USD 4,200,000|
|SpineZone||Developer of personalized treatment programs for neck and back pain.||Series A||USD 12,000,000|
|Maridose LLC||Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.||Pre Seed||USD 150,000|
|Pluto Health||Smart health assistant providing insights from siloed medical data.||Pre Seed|
|Aarogoya AI||AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.||Seed|
|Babylon Health||Series C||USD 550,000,000|
|Enlitic LLC||Developer of machine learning algorithmic tools for analysing medical data.||Series B||USD 15,000,000|
|AccuRx Ltd||Platform to power communications between patients and their healthcare professionals.||Series A||GBP 8,800,000|
|Current Health Ltd||Software-based storage platform used by medical teams to monitor vital signs.||Venture|
MOST ACTIVE INVESTORS
Cancer drug development company.
DNA testing and genome sequencing firm.
Liquid biopsy diagnosis platform.
Developer of machine learning algorithmic tools for analysing medical data.
Global proof engine.
Oxford University spinout focused on designing stem cell drugs to treat age-related diseases.
Developer of personalized treatment programs for neck and back pain.
Platform to power communications between patients and their healthcare professionals.
In-game currency of the OliveX, fitness metaverse.
Maker of a connected electric toothbrush.
Consortium of healthcare companies focused on accelerating meaningful innovation using blockchain and DLT.
Provider of online mental health tools for college students who suffer from depression and anxiety.
Developer of a personal health data platform that enables any American to collect, personalize, and share a picture of their health data.
Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.